MTD vs ROIV
Mettler-Toledo International Inc. and Roivant Sciences Ltd. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Mettler-Toledo International Inc. (MTD) | Roivant Sciences Ltd. (ROIV) | |
|---|---|---|
| Market cap | $22.8B | $20.5B |
| Revenue (latest FY) | $4.03B | $8.26M |
| Net income (latest FY) | $869.19M | $-299.77M |
| Revenue growth (5y CAGR) | 5.5% | -19.1% |
| Net margin | 21.6% | -3629.2% |
| Return on equity | -3677.4% | -6.6% |
| P/E ratio | 26.5 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 1 |
| Positive free cash flow | Yes | No |
See the full MTD vs ROIV breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open MTD's full financials → Open ROIV's full financials →More comparisons
Frequently asked questions
Which is bigger, MTD or ROIV?
Mettler-Toledo International Inc. is larger by market capitalization — $22.8B versus $20.5B.
Which grows faster, MTD or ROIV?
Over the last five fiscal years, Mettler-Toledo International Inc. grew revenue faster — 5.5%/yr versus -19.1%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
MTD fundamentals → · ROIV fundamentals → · All 1,500+ companies → · Free screener →